To confirm the efficacy of HGF in reducing corneal opacity formation and preserving transparency following LPS keratitis, we investigated whether HGF inhibits the expression of α-smooth muscle actin (α-SMA), a marker of fibrosis, following LPS injection. This evidence concerns the gene ACTA1 and keratitis.